Cingulate Inc — Stato Patrimoniale (NASDAQ:CING)

Financials

Totale attivo 22.89 M11.41 M3.49 M14.86 M15.07 M Totale passività 2.04 M7.52 M10.36 M7.41 M12.56 M Patrimonio netto totale 20.84 M3.88 M-6.87 M7.46 M2.51 M Totale passività e patrimonio netto 22.89 M11.41 M3.49 M14.86 M15.07 M Debito totale 1.12 M5.83 M2.59 M4.97 M7.45 M Indebitamento netto -15.37 M472.23 K2.54 M-7.24 M-3.51 M

Notizie

Cingulate aumenta il limite dell’offerta at-the-market a 31,9 milioni di dollari

Cingulate increases at-the-market offering limit to $31.9 million

Cingulate ripristina Shane Schaffer come CEO e aggiorna i termini di impiego

Cingulate reinstates Shane Schaffer as CEO, updates employment terms

Cingulate appoints new CCO, secures $6 million financing

Cingulate’s ADHD drug meets primary endpoints in phase 3 trial

La FDA accetta la domanda per il farmaco ADHD di Cingulate, fissa la data per maggio 2026

FDA accepts Cingulate’s ADHD drug application, sets May 2026 target date

Cingulate sigla accordo di produzione con Bend Bio Sciences per farmaco ADHD

Cingulate secures manufacturing deal with Bend Bio Sciences for ADHD drug

Cingulate issues shares to lender in series of unregistered transactions

Cingulate appoints John A. Roberts as executive chairman, CEO placed on leave